These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9234733)

  • 1. Illegitimate recombination leading to allelic loss and unbalanced translocation in p53-mutated human lymphoblastoid cells.
    Honma M; Zhang LS; Hayashi M; Takeshita K; Nakagawa Y; Tanaka N; Sofuni T
    Mol Cell Biol; 1997 Aug; 17(8):4774-81. PubMed ID: 9234733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement of wild-type p53 protein for maintenance of chromosomal integrity.
    Honma M; Momose M; Tanabe H; Sakamoto H; Yu Y; Little JB; Sofuni T; Hayashi M
    Mol Carcinog; 2000 Aug; 28(4):203-14. PubMed ID: 10972990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic and mutagenic responses to X-rays and chemical mutagens in normal and p53-mutated human lymphoblastoid cells.
    Honma M; Hayashi M; Sofuni T
    Mutat Res; 1997 Mar; 374(1):89-98. PubMed ID: 9067419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells.
    Honma M
    Environ Mol Mutagen; 2005; 45(2-3):162-76. PubMed ID: 15688360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different capacities for recombination in closely related human lymphoblastoid cell lines with different mutational responses to X-irradiation.
    Xia F; Amundson SA; Nickoloff JA; Liber HL
    Mol Cell Biol; 1994 Sep; 14(9):5850-7. PubMed ID: 8065318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different mechanisms of radiation-induced loss of heterozygosity in two human lymphoid cell lines from a single donor.
    Wiese C; Gauny SS; Liu WC; Cherbonnel-Lasserre CL; Kronenberg A
    Cancer Res; 2001 Feb; 61(3):1129-37. PubMed ID: 11221843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive loss of heterozygosity is suppressed during homologous repair of chromosomal breaks.
    Stark JM; Jasin M
    Mol Cell Biol; 2003 Jan; 23(2):733-43. PubMed ID: 12509470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further characterization of loss of heterozygosity enhanced by p53 abrogation in human lymphoblastoid TK6 cells: disappearance of endpoint hotspots.
    Yatagai F; Morimoto S; Kato T; Honma M
    Mutat Res; 2004 Jun; 560(2):133-45. PubMed ID: 15157651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and molecular characterization of spontaneous mutants of lymphoblastoid cells with extended loss of heterozygosity.
    de Nooij-van Dalen AG; van Buuren-van Seggelen VH; Mulder A; Gelsthorpe K; Cole J; Lohman PH; Giphart-Gassler M
    Mutat Res; 1997 Mar; 374(1):51-62. PubMed ID: 9067415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of genetic alterations induced by low-dose X rays: analysis of loss of heterozygosity for TK mutation in human lymphoblastoid cells.
    Morimoto S; Kato T; Honma M; Hayashi M; Hanaoka F; Yatagai F
    Radiat Res; 2002 May; 157(5):533-8. PubMed ID: 11966319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor suppressor p53 modifies mutational processes in a human lymphoblastoid cell line.
    Xia F; Liber HL
    Mutat Res; 1997 Jan; 373(1):87-97. PubMed ID: 9015157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity.
    Caron H; van Sluis P; van Roy N; de Kraker J; Speleman F; Voûte PA; Westerveld A; Slater R; Versteeg R
    Am J Hum Genet; 1994 Aug; 55(2):341-7. PubMed ID: 8037211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenic radioadaptation in a human lymphoblastoid cell line.
    Yatagai F; Umebayashi Y; Honma M; Sugasawa K; Takayama Y; Hanaoka F
    Mutat Res; 2008 Feb; 638(1-2):48-55. PubMed ID: 17919664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of mutagenesis in human cells exposed to 55 MeV protons.
    Gauny S; Wiese C; Kronenberg A
    Phys Med; 2001; 17 Suppl 1():235-7. PubMed ID: 11776985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus.
    Okamoto A; Sameshima Y; Yamada Y; Teshima S; Terashima Y; Terada M; Yokota J
    Cancer Res; 1991 Oct; 51(20):5632-5. PubMed ID: 1913680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of spontaneous and induced loss of heterozygosity in human cells in vitro.
    Li CY; Yandell DW; Little JB
    Somat Cell Mol Genet; 1992 Jan; 18(1):77-87. PubMed ID: 1546370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline levels of chromosome instability in the human lymphoblastoid cell TK6.
    Schwartz JL; Jordan R; Evans HH; Lenarczyk M; Liber HL
    Mutagenesis; 2004 Nov; 19(6):477-82. PubMed ID: 15548760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive detection of LOH events in a human cell line after C-ion beam exposure.
    Morimoto S; Honma M; Yatagai F
    J Radiat Res; 2002 Dec; 43 Suppl():S163-7. PubMed ID: 12793752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion, rearrangement, and gene conversion; genetic consequences of chromosomal double-strand breaks in human cells.
    Honma M; Izumi M; Sakuraba M; Tadokoro S; Sakamoto H; Wang W; Yatagai F; Hayashi M
    Environ Mol Mutagen; 2003; 42(4):288-98. PubMed ID: 14673874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant transformation of human fibroblast cell strain MSU-1.1 by N-methyl-N-nitrosourea: evidence of elimination of p53 by homologous recombination.
    Boley SE; McManus TP; Maher VM; McCormick JJ
    Cancer Res; 2000 Aug; 60(15):4105-11. PubMed ID: 10945617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.